Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Immunity found in UK bats

Disease-causing fungus has no apparent effect in Europe

It is thought that UK bats could be immune to a fungus associated with the deaths of more that 5.7 million bats in North America since 2006.

Psuedogymnoascus destructans, a fungus that is the known cause of the disease White-Nose Syndrome (WNS) in bats, has been discovered in the UK for the first time.

Despite samples being collected and tested across five sites in Kent and Sussex, as far as scientists are aware, the fungus has not resulted in any bat deaths in the country.

It is therefore believed that UK bats are immune to the disease, particularly since one
tested fit and healthy after being found with the fungus on its ear.

WNS affects hibernation, thus causing the mammals to use up fat reserves that cannot be replaced due to lack of available food and water during the winter season. As a result, the disease causes death to large numbers of dehydrated, underweight bats every year in North America.

However, the fungus has also been confirmed in sites across Europe, with no reported related deaths.

Julia Hanmer, chief executive of Bat Conservation Trust, said: "In North America, the fungus causes WNS and millions of bats have died. In Europe, the fungus has been found on bats, but the difference is these animals are alive and appear to be healthy."

She added that there is no evidence of WNS in Europe, despite reason to believe the fungus has been present here for a long time.

"European bats have developed resilience to it," explained Ms Hanmer. "The fungus was most likely introduced to North America from this side of the Atlantic, hence the dramatic effect it is having on bat populations there, as they have no immunity to the disease."

Related News
Bat genes could hold clues for cancer treatment
Study reveals rabid bats have cooler faces

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.